0.00
price down icon100.00%   -0.06
 
loading

Nkgen Biotech Inc (NKGN) 最新ニュース

pulisher
Feb 26, 2026

NKGen Biotech Secures Additional Debt Financing from AlpineBrook - TipRanks

Feb 26, 2026
pulisher
Feb 26, 2026

Nkgen Biotech amends loan agreement to secure additional $343,000 funding - Investing.com

Feb 26, 2026
pulisher
Feb 26, 2026

NKGen Biotech Adds $343,000 via Fourth Amendment to AlpineBrook Secured Note; Principal Now $27.1M - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

NKGen Biotech (NKGN) adds $343,000 under AlpineBrook note - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

NKGen Biotech, Inc. and NKGen Operating Biotech, Inc. Enter Amendment to Secured Promissory Note Increases Loan Principal and Funding - marketscreener.com

Feb 26, 2026
pulisher
Feb 25, 2026

NKGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 25, 2026
pulisher
Feb 22, 2026

NKGNNKGen Biotech Inc Latest Stock News & Market Updates - Stock Titan

Feb 22, 2026
pulisher
Feb 05, 2026

NKGen Biotech increases loan principal by $251,000 under amended agreement By Investing.com - Investing.com Nigeria

Feb 05, 2026
pulisher
Feb 05, 2026

NKGen Biotech increases loan principal by $251,000 under amended agreement - Investing.com South Africa

Feb 05, 2026
pulisher
Feb 05, 2026

NKGen Biotech expands debt financing with loan amendment - TipRanks

Feb 05, 2026
pulisher
Feb 05, 2026

NKGen Biotech Signs Amendment to Secured Promissory Note With AlpineBrook Capital - TradingView

Feb 05, 2026
pulisher
Feb 05, 2026

Pre-Market Top Gainer: NKGNW NKGen Warrants NASDAQ $0.0301 Feb 2026: key setup - Meyka

Feb 05, 2026
pulisher
Feb 02, 2026

Head to Head Comparison: NKGen Biotech (NYSE:NKGN) versus SQZ Biotechnologies (NYSE:SQZ) - Defense World

Feb 02, 2026
pulisher
Jan 26, 2026

NKGen Biotech amends loan agreement and extends forward purchase deal By Investing.com - Investing.com Nigeria

Jan 26, 2026
pulisher
Jan 26, 2026

NKGen Biotech amends loan agreement and extends forward purchase deal - Investing.com

Jan 26, 2026
pulisher
Jan 26, 2026

NKGen Biotech Secures Additional Funding via Note Amendment - TipRanks

Jan 26, 2026
pulisher
Jan 26, 2026

NKGen Biotech Signs Multiple Financing Agreements - TradingView

Jan 26, 2026
pulisher
Jan 24, 2026

NKGen Biotech confirms successful acquisition of NKMax - intellectia.ai

Jan 24, 2026
pulisher
Jan 24, 2026

NKGen Biotech Appoints Bruce Miller to Scientific Advisory Board - Intellectia AI

Jan 24, 2026
pulisher
Jan 23, 2026

NKGen Biotech appoints neurology expert Dr. Bruce Miller to advisory board - Investing.com Nigeria

Jan 23, 2026
pulisher
Jan 22, 2026

NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board - The Globe and Mail

Jan 22, 2026
pulisher
Jan 20, 2026

NKGen Biotech, Inc. SEC 10-Q Report - TradingView — Track All Markets

Jan 20, 2026
pulisher
Jan 16, 2026

Nkgen Biotech amends loan agreement to secure additional $295,000 funding - Investing.com India

Jan 16, 2026
pulisher
Jan 16, 2026

Nkgen Biotech amends loan agreement to secure additional $295,000 funding By Investing.com - Investing.com South Africa

Jan 16, 2026
pulisher
Jan 16, 2026

NKGen Biotech Expands Debt Financing Through Note Amendment - TipRanks

Jan 16, 2026
pulisher
Jan 16, 2026

NKGen Biotech Signs Amendment to Secured Promissory Note With AlpineBrook Capital GP I - TradingView — Track All Markets

Jan 16, 2026
pulisher
Jan 16, 2026

NKGen Biotech, Inc. and NKGen Operating Biotech, Inc., Enter into an Amendment to Certain Secured Promissory Note with AlpineBrook Capital GP I Limited - marketscreener.com

Jan 16, 2026
pulisher
Jan 10, 2026

NKGen Biotech enters $25.8 million secured note agreement with AlpineBrook Capital - Investing.com Australia

Jan 10, 2026
pulisher
Jan 09, 2026

NKGen Biotech enters $25.8 million secured note agreement with AlpineBrook Capital By Investing.com - Investing.com South Africa

Jan 09, 2026
pulisher
Jan 09, 2026

NKGen Biotech Secures New Promissory Note Financing - TipRanks

Jan 09, 2026
pulisher
Jan 09, 2026

NKGen Biotech Signs Secured Promissory Note With AlpineBrook Capital GP I - TradingView

Jan 09, 2026
pulisher
Jan 01, 2026

NKGen Biotech issues statement on NKGen Korea board appointments - MSN

Jan 01, 2026
pulisher
Jan 01, 2026

Financial Review: Alpha Cognition (OTC:ACOGF) vs. NKGen Biotech (NYSE:NKGN) - Defense World

Jan 01, 2026
pulisher
Dec 11, 2025

Analyzing Genocea Biosciences (NASDAQ:GNCA) and NKGen Biotech (NYSE:NKGN) - Defense World

Dec 11, 2025
pulisher
Dec 03, 2025

NKGen Biotech, Inc. Issues Statement on Recent Board - GlobeNewswire

Dec 03, 2025
pulisher
Dec 02, 2025

Is NKGen Biotech, Inc. technically bullish or bearish? - Markets Mojo

Dec 02, 2025
pulisher
Nov 26, 2025

NKGen Biotech announces new funding to regain compliance with reporting obligations and listing standards - MSN

Nov 26, 2025
pulisher
Nov 21, 2025

NKMAX CO., Ltd. has Changed its Name to NKGen Korea - marketscreener.com

Nov 21, 2025
pulisher
Nov 19, 2025

Sorrento Therapeutics (NASDAQ:SRNE) versus NKGen Biotech (NYSE:NKGN) Head-To-Head Review - Defense World

Nov 19, 2025
pulisher
Nov 15, 2025

Sorrento Therapeutics (OTCMKTS:SRNEQ) & NKGen Biotech (NYSE:NKGN) Head-To-Head Review - Defense World

Nov 15, 2025
pulisher
Nov 13, 2025

Reviewing NKGen Biotech (NYSE:NKGN) and Sorrento Therapeutics (OTCMKTS:SRNEQ) - Defense World

Nov 13, 2025
pulisher
Nov 04, 2025

Total debt per share of NKGen Biotech Inc. – OTC:NKGN - TradingView

Nov 04, 2025
pulisher
Nov 04, 2025

Revenue per share of NKGen Biotech Inc. – OTC:NKGN - TradingView

Nov 04, 2025
pulisher
Nov 01, 2025

NKGen Biotech, Inc. (NKGN) Eps Diluted (Quarterly) - Zacks Investment Research

Nov 01, 2025
pulisher
Oct 27, 2025

Nkgen Biotech’s Promising Alzheimer’s Study: A Potential Game-Changer? - TipRanks

Oct 27, 2025
$45.97
price up icon 0.28%
$83.89
price down icon 17.88%
$29.70
price up icon 0.58%
$54.98
price down icon 1.36%
$143.85
price up icon 0.50%
biotechnology ONC
$305.39
price up icon 1.03%
大文字化:     |  ボリューム (24 時間):